Alector Stock (NASDAQ: ALEC) stock price, news, charts, stock research, profile.
Open | $5.240 |
Close | $5.250 |
Volume / Avg. | 456.824K / 603.247K |
Day Range | 5.215 - 5.510 |
52 Wk Range | 3.660 - 9.065 |
Market Cap | $506.019M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 10.25% |
Days to Cover | 9.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alector (NASDAQ: ALEC) through any online brokerage.
Other companies in Alector’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Voyager Therapeutics (NASDAQ:VYGR).
The latest price target for Alector (NASDAQ: ALEC) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 35.00 expecting ALEC to rise to within 12 months (a possible 566.67% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Alector (NASDAQ: ALEC) is $5.25 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Alector.
Alector’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Alector.
Alector is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.